-- 週四,馬來西亞棕櫚油期貨價格從近兩週高點回落,因為交易員獲利了結,且疲軟的出口抵消了厄爾尼諾現象導致供應趨緊的預期。 馬來西亞衍生性商品交易所5月原棕櫚油合約結束了連續三個交易日的上漲勢頭,下跌0.2%,至每噸4,540馬來西亞林吉特(1,144.73美元)。 6月合約午盤也下跌了相同的幅度,至每噸4,591林吉特。 本週迄今為止,這兩個合約均上漲超過3.5%,扭轉了先前連續兩週的跌勢。 儘管原油價格上漲且當地貨幣走軟,但棕櫚油價格週四仍出現下跌。 本月出口需求疲軟,據報道,貨運調查員預計,4月前20天馬來西亞的棕櫚油出貨量將季減25.6%至25.8%,主要原因是中東地區的需求下降。 儘管如此,東南亞生產商在經濟效益改善的背景下,為滿足國內市場需求,並應對持續的供應鏈中斷,擴大生物燃料的使用,將支撐棕櫚油價格的未來走勢。 印尼、馬來西亞和泰國生物柴油計畫的增加,以及厄爾尼諾現象對棕櫚油產量的潛在影響,將導致供應趨緊。 據價格報告機構MySteel稱,由於市場正在關注極端天氣條件對棕櫚油生產的影響,「價格仍有上漲空間」。 MySteel預計,棕櫚油價格短期內將在波動區間內交易。 馬來西亞《The Edge》引述BMI Research的報導稱,厄爾尼諾現象的擔憂將成為棕櫚油價格的支撐因素,並緩解地緣政治風險溢價下降帶來的價格下跌。 據報道,短期內,預計美伊衝突的發展將繼續影響市場趨勢,假設中東衝突降級,棕櫚油價格可能會在第二季度下滑至每噸 4,200 林吉特左右。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.